Life Sciences & Health Care
Rapid transformation in the life sciences and health care industry can require businesses to strike a balance between patient demands, market potential, and policy compliance, while continuing to innovate. We create solutions that can help you remain competitive in this constantly evolving market.
For a more innovative, equitable, and sustainable future
Innovation is blurring the traditional boundaries in the life sciences and health care industry. Our extensive industry experience, differentiated market research, data, and insights give us a comprehensive understanding of the opportunities and challenges of the changing health care ecosystem.
We are positioned to help you drive your business forward—not only because we understand complex problems, but because we have the skills, tools, and multi-disciplinary solutions to help solve them. Through deep understanding of our vision of the Future of Health™, health equity and digital transformation, we can help you navigate the industry’s transformation as exponential innovation propels health care to the future.
Our Thinking
Empowering the health care workforce for a climate-resilient future
In this report, Project HOPE and Deloitte US have brought together frontline health care workers, program leaders, health system advisors, policy and advocacy professionals, community leaders, and strategic relationships to collaborate on potential solutions for enhancing climate resilience.
Platform business models: Private equity opportunities in the life sciences and health care sector
Platform businesses are rewiring the traditional value chain. In nearly every industry, well-thought-out platform businesses typically beat traditional businesses because of superior unit economics and network effects.
Electronic Health Records Solution
Deloitte's Electronic Health Record (EHR) solution helps health systems execute digital transformation that shifts legacy models into modern best practices anchored on elevating the human experience.
2024 Global Life Sciences Sector Outlook
With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro-economic drivers to guide their future growth.
A path toward health equity
The COVID-19 pandemic exposed a glaring disparity in global vaccine access. The World Economic Forum (WEF) and Deloitte have been collaborating to tackle this challenge by advocating for regionalized vaccine manufacturing ecosystems. This approach aims to revolutionize vaccine production and distribution, promoting equity and resilience in the face of future health crises.
Deloitte at HLTH Europe
From digital health to biotech and from digital therapeutics to health care IT innovations, there’s a community and a conversation about it at HLTH Europe event.
Global Health Equity Network Zero Health Gaps Pledge
Deloitte is honored to be one of a growing list of 60+ signatories of the Zero Health Gaps Pledge, the first global, multi-sector, CEO-level pledge to help advance health equity.
Securing trust in the global supply chain of COVID-19 vaccines
The critical success factors identified in 2020 remain paramount. But now stakeholders need to act on the lessons learned to strengthen the collective ability to respond to or—better yet—proactively address the existing global health issues.
The promise of digital mental health in a meta world
A Deloitte and World Economic Forum report
Explore the Life Sciences & Health Care industry
Vicky Levy
